43rd Annual Southeastern Consortium for Dermatology

Meeting Handouts & Disclosures

Click any one the following links to download handout:

Friday, October 4

1:00 pm        Cutting Edge Treatment of HS Now and in the Future

1:30 pm        Update on Melanoma

2:00 pm        Psoriasis: Which Drug to Choose When

2:30 pm        Advances in the Treatment of Autoimmune Blistering Diseases

3:30 pm        Pedicures, Lasers, and other Mycobabacterial Adventures

4:00 pm        Clinical Pearls and Tips for HPV/Condyloma

4:30 pm        Short Term Experiences in Global Health (STEGHs): Myths, Realities, and Infections

5:00 pm        Dermatopathology of Infectious Diseases

Saturday, October 5

8:00 am         Pathological Assessment of Hair Loss

8:25 am         Pre-JAK Inhibitors: What Works and What Doesn’t

8:50 am         To Come – New Thoughts on Etiology Factors for Alopecia Areata (Lund Lecturer)

9:35 am         To Come  – JAK Inhibitors for Alopecia Areata

10:40 am       Evaluation and Management of Female Pattern Hair Loss

11:05 am        Frontal Fibrosing Alopecia, PRP and Microneedling

11:35 am        Update in Central Centrifugal Cicatricial Alopecia

12:05 pm        To Come – Future Directions in Male and Female Pattern Hair Loss (Callaway Lecturer)

Summary of Faculty Disclosures/Planning Committee

The following speakers and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CME activity:  Angela Christiano, PhD; Dirk Elston, MD; MHS; Russell Hall, MD; Tiffany Mayo, MD; Elise Olsen, MD; Samantha Wennerberg, PA; Sarah Wolfe, MD; Carrie Kovarik, MD; Benjamin Stoff, MD, MA; Jason Stout, MD; Abby Van Voorhees, MD

The following speakers and/or planning committee members have indicated that they have relationship(s) with industry to disclose:

George Cotsarelis, MD has indicated that he is on the Advisory Board for Follica.
James Grichnik, MD has indicated that he is a stockholder of DigitalDerm.
Amy McMichael, MD has indicated that she receives royalties from Informa Healthcare
Chris Sayed, MD has indicated that he is a speaker for Abbvie and Novartis.
Jerry Shapiro, MD is on the Advisory Board for Incyte and Aclaris, and a stockholder of Replicel.